These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104. Genetic and inflammatory factors associated with psoriatic arthritis: Relevance to diagnosis and management. Furst DE; Belasco J; Louie JS Clin Immunol; 2019 May; 202():59-75. PubMed ID: 30738143 [TBL] [Abstract][Full Text] [Related]
105. Racial disparities in comorbidities of patients with psoriatic arthritis. Ross Y; Jaleel S; Magrey M Rheumatol Int; 2023 Aug; 43(8):1525-1529. PubMed ID: 37017711 [TBL] [Abstract][Full Text] [Related]
106. Multidisciplinary Management of Psoriatic Arthritis: The Benefits of a Comprehensive Approach. Visalli E; Crispino N; Foti R Adv Ther; 2019 Apr; 36(4):806-816. PubMed ID: 30805821 [TBL] [Abstract][Full Text] [Related]
107. Unmet needs in psoriatic arthritis patients receiving immunomodulatory therapy: results from a large multinational real-world study. Alten R; Conaghan PG; Strand V; Sullivan E; Blackburn S; Tian H; Gandhi K; Jugl SM; Deodhar A Clin Rheumatol; 2019 Jun; 38(6):1615-1626. PubMed ID: 30719594 [TBL] [Abstract][Full Text] [Related]
108. Reproductive Healthcare in Women with Rheumatoid Arthritis and Psoriatic Diseases in Routine Clinical Practice: Survey Results of Rheumatologists and Dermatologists. Olejárová M; Macejová Ž; Gkalpakiotis S; Procházková L; Tóth Z; Prágr P Rheumatol Ther; 2022 Dec; 9(6):1575-1586. PubMed ID: 36152274 [TBL] [Abstract][Full Text] [Related]
109. Unmet needs in psoriatic arthritis. Ng BCK; Jadon DR Best Pract Res Clin Rheumatol; 2021 Jun; 35(2):101693. PubMed ID: 34099367 [TBL] [Abstract][Full Text] [Related]
112. Access to high-cost medications for psoriatic arthritis in the National Health System in Brazil: the long path up to dispensation. da Silva MRR; Dos Santos JBR; Almeida AM; Alvares-Teodoro J; Kakehasi AM; Acurcio FA Adv Rheumatol; 2019 Nov; 59(1):48. PubMed ID: 31727164 [TBL] [Abstract][Full Text] [Related]
113. [Cross-sectional study on clinic behavior and therapeutic status of patients with psoriatic arthritis in multi-center]. Li YH; Su B; Lin FA; Fei YN; Yu XX; Fan WQ; Chen HY; Zhang XW; Jia Y Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Dec; 51(6):1014-1018. PubMed ID: 31848496 [TBL] [Abstract][Full Text] [Related]
114. Horizon scan: State-of-the-art therapeutics for psoriatic arthritis. Hutton J; Mease P; Jadon D Best Pract Res Clin Rheumatol; 2022 Dec; 36(4):101809. PubMed ID: 36567224 [TBL] [Abstract][Full Text] [Related]
115. Making the next steps in psoriatic arthritis management: current status and future directions. Sritheran D; Leung YY Ther Adv Musculoskelet Dis; 2015 Oct; 7(5):173-86. PubMed ID: 26425146 [TBL] [Abstract][Full Text] [Related]
116. Consensus statements for evaluation and nonpharmacological Management of Psoriatic Arthritis in UAE. Alnaqbi KA; Hannawi S; Namas R; Alshehhi W; Badsha H; Al-Saleh J Int J Rheum Dis; 2022 Jul; 25(7):725-732. PubMed ID: 35678066 [TBL] [Abstract][Full Text] [Related]
117. Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey. Coates LC; Azevedo VF; Cappelleri JC; Moser J; Eder L; Richette P; Weng MY; Silva RQ; Garg A; Majjhoo A; Griffiths CEM; Young P; Howland S Rheumatol Ther; 2021 Dec; 8(4):1741-1758. PubMed ID: 34570345 [TBL] [Abstract][Full Text] [Related]
118. How well are biologic and conventional DMARDs tolerated in psoriatic arthritis: A real world study. Jawad II; Nisar MK Eur J Rheumatol; 2022 Apr; 9(2):100-103. PubMed ID: 35156631 [TBL] [Abstract][Full Text] [Related]
119. Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey. Lim I; Richette P; Queiro-Silva R; Moser J; Cappelleri JC; Ng HY; Witcombe D Rheumatol Ther; 2021 Jun; 8(2):761-774. PubMed ID: 33761131 [TBL] [Abstract][Full Text] [Related]